In our last podcast, we touched on topics around:1. policy breakthroughs and current regulatory barriers in pilot zones across China,2. applying real-world data to streamline the review of imported medical products,3. the l...

In this podcast, we will mostly dive into some of the latest but also long-standing industry and regulatory issues in China surrounding the accessibility of innovative healthcare products, their current policy regulation standings, and what are...